Find Clinical Trials
Efficacy and safety of 3 doses of S 38093 (2, 5 and 20 mg/day) versus placebo in patients with mild to moderate Alzheimer’s disease. A 24- week international, multi-centre, randomised, double-blind, placebo-controlled phase IIb study followed by a 24-week extension period
Servier Protocol Code:
CL2-38093-011
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2010-024626-37
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Alzheimer's disease
- S038093
Other study id numbers
Other identification numbers the study may be known by.
- CL2-38093-011